てんかん薬の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)

【英語タイトル】Global Epilepsy Drugs Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

GlobalInfoResearchが出版した調査資料(GIR8102226)・商品コード:GIR8102226
・発行会社(調査会社):GlobalInfoResearch
・発行日:2018年10月12日(※2024年版があります。お問い合わせください)
・ページ数:147
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:世界
・産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートは、てんかん薬の世界市場について調べ、まとめました。種類別セグメントは、第一世代、第二世代等、用途別セグメントは、病院薬局、小売薬局、オンライン薬局等に区分しました。てんかん薬の世界市場概観、メーカー動向、メーカー別てんかん薬シェア、市場規模推移、市場規模予測、主要地域分析(北米、ヨーロッパ、アジア等)、主要国分析(日本、中国、アメリカ等)データなどの情報が含まれています。
・てんかん薬の市場概観
・てんかん薬のメーカー概要(事業概要、製品種類、価格、売上、市場シェア等)
・てんかん薬のメーカー別販売動向、市場シェア、市場集中度、競争動向
・てんかん薬の世界市場規模
・てんかん薬の北米市場分析(アメリカ、カナダ、メキシコ等)
・てんかん薬のアメリカ市場規模推移
・てんかん薬のカナダ市場規模推移
・てんかん薬のメキシコ市場規模推移
・てんかん薬のヨーロッパ市場分析(ドイツ、イギリス、ロシア、フランス、イタリア等)
・てんかん薬のドイツ市場規模推移
・てんかん薬のイギリス市場規模推移
・てんかん薬のロシア市場規模推移
・てんかん薬のアジア市場分析(日本、中国、韓国、インド、東南アジア等)
・てんかん薬の日本市場規模推移
・てんかん薬の中国市場規模推移
・てんかん薬の韓国市場規模推移
・てんかん薬のインド市場規模推移
・てんかん薬の東南アジア市場規模推移
・てんかん薬の南米市場分析(ブラジル、アルゼンチン等)
・てんかん薬の中東・アフリカ市場分析(サウジアラビア、UAE、南アフリカ等)
・てんかん薬の種類別分析/市場規模推移(第一世代、第二世代)
・てんかん薬の用途別分析/市場規模推移(病院薬局、小売薬局、オンライン薬局)
・てんかん薬の市場予測(地域別予測、種類別予測、用途別予測)
・てんかん薬の販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

Epilepsy is characterized by recurrent seizures caused by the improper balance between inhibitory and excitatory signals in the brain. The symptoms of epilepsy, caused by brain malformations and tumors, birth trauma, and high-risk pregnancies, can be benign or life-threatening. A majority of epilepsy cases have an unknown etiology.

Scope of the Report:

This report studies the Epilepsy Drugs market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Epilepsy Drugs market by product type and applications/end industries.

In terms of geography, the Americas led the global epilepsy drugs market and is likely to hold close to 50% of the revenue market shares. The growth of this market in the region is due to the high prevalence of the disorder and the availability of treatment options in the region, especially in the developed markets such as the US and Canada.

The global Epilepsy Drugs market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Epilepsy Drugs.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Abbott Laboratories

GlaxoSmithKline Plc

UCB

Cephalon

Johnson & Johnson

Pfizer

Novartis AG

Abbvie

Janssen Pharmaceuticals

Sunovion Pharmaceuticals

Valeant Pharmaceuticals International

Sanofi S.A

Shire

Eisai

F. Hoffmann-La Roche

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

First Generation

Second Generation

Market Segment by Applications, can be divided into

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

【レポートの目次】

Table of Contents

1 Epilepsy Drugs Market Overview

1.1 Product Overview and Scope of Epilepsy Drugs

1.2 Classification of Epilepsy Drugs by Types

1.2.1 Global Epilepsy Drugs Revenue Comparison by Types (2017-2023)

1.2.2 Global Epilepsy Drugs Revenue Market Share by Types in 2017

1.2.3 First Generation

1.2.4 Second Generation

1.3 Global Epilepsy Drugs Market by Application

1.3.1 Global Epilepsy Drugs Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Global Epilepsy Drugs Market by Regions

1.4.1 Global Epilepsy Drugs Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Epilepsy Drugs Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Epilepsy Drugs Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Epilepsy Drugs Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Epilepsy Drugs Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Epilepsy Drugs Status and Prospect (2013-2023)

1.5 Global Market Size of Epilepsy Drugs (2013-2023)

2 Manufacturers Profiles

2.1 Abbott Laboratories

2.1.1 Business Overview

2.1.2 Epilepsy Drugs Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Abbott Laboratories Epilepsy Drugs Revenue, Gross Margin and Market Share (2016-2017)

2.2 GlaxoSmithKline Plc

2.2.1 Business Overview

2.2.2 Epilepsy Drugs Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 GlaxoSmithKline Plc Epilepsy Drugs Revenue, Gross Margin and Market Share (2016-2017)

2.3 UCB

2.3.1 Business Overview

2.3.2 Epilepsy Drugs Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 UCB Epilepsy Drugs Revenue, Gross Margin and Market Share (2016-2017)

2.4 Cephalon

2.4.1 Business Overview

2.4.2 Epilepsy Drugs Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Cephalon Epilepsy Drugs Revenue, Gross Margin and Market Share (2016-2017)

2.5 Johnson & Johnson

2.5.1 Business Overview

2.5.2 Epilepsy Drugs Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Johnson & Johnson Epilepsy Drugs Revenue, Gross Margin and Market Share (2016-2017)

2.6 Pfizer

2.6.1 Business Overview

2.6.2 Epilepsy Drugs Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Pfizer Epilepsy Drugs Revenue, Gross Margin and Market Share (2016-2017)

2.7 Novartis AG

2.7.1 Business Overview

2.7.2 Epilepsy Drugs Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Novartis AG Epilepsy Drugs Revenue, Gross Margin and Market Share (2016-2017)

2.8 Abbvie

2.8.1 Business Overview

2.8.2 Epilepsy Drugs Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Abbvie Epilepsy Drugs Revenue, Gross Margin and Market Share (2016-2017)

2.9 Janssen Pharmaceuticals

2.9.1 Business Overview

2.9.2 Epilepsy Drugs Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Janssen Pharmaceuticals Epilepsy Drugs Revenue, Gross Margin and Market Share (2016-2017)

2.10 Sunovion Pharmaceuticals

2.10.1 Business Overview

2.10.2 Epilepsy Drugs Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Sunovion Pharmaceuticals Epilepsy Drugs Revenue, Gross Margin and Market Share (2016-2017)

2.11 Valeant Pharmaceuticals International

2.11.1 Business Overview

2.11.2 Epilepsy Drugs Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Valeant Pharmaceuticals International Epilepsy Drugs Revenue, Gross Margin and Market Share (2016-2017)

2.12 Sanofi S.A

2.12.1 Business Overview

2.12.2 Epilepsy Drugs Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Sanofi S.A Epilepsy Drugs Revenue, Gross Margin and Market Share (2016-2017)

2.13 Shire

2.13.1 Business Overview

2.13.2 Epilepsy Drugs Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 Shire Epilepsy Drugs Revenue, Gross Margin and Market Share (2016-2017)

2.14 Eisai

2.14.1 Business Overview

2.14.2 Epilepsy Drugs Type and Applications

2.14.2.1 Product A

2.14.2.2 Product B

2.14.3 Eisai Epilepsy Drugs Revenue, Gross Margin and Market Share (2016-2017)

2.15 F. Hoffmann-La Roche

2.15.1 Business Overview

2.15.2 Epilepsy Drugs Type and Applications

2.15.2.1 Product A

2.15.2.2 Product B

2.15.3 F. Hoffmann-La Roche Epilepsy Drugs Revenue, Gross Margin and Market Share (2016-2017)

3 Global Epilepsy Drugs Market Competition, by Players

3.1 Global Epilepsy Drugs Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Epilepsy Drugs Players Market Share

3.2.2 Top 10 Epilepsy Drugs Players Market Share

3.3 Market Competition Trend

4 Global Epilepsy Drugs Market Size by Regions

4.1 Global Epilepsy Drugs Revenue and Market Share by Regions

4.2 North America Epilepsy Drugs Revenue and Growth Rate (2013-2018)

4.3 Europe Epilepsy Drugs Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Epilepsy Drugs Revenue and Growth Rate (2013-2018)

4.5 South America Epilepsy Drugs Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Epilepsy Drugs Revenue and Growth Rate (2013-2018)

5 North America Epilepsy Drugs Revenue by Countries

5.1 North America Epilepsy Drugs Revenue by Countries (2013-2018)

5.2 USA Epilepsy Drugs Revenue and Growth Rate (2013-2018)

5.3 Canada Epilepsy Drugs Revenue and Growth Rate (2013-2018)

5.4 Mexico Epilepsy Drugs Revenue and Growth Rate (2013-2018)

6 Europe Epilepsy Drugs Revenue by Countries

6.1 Europe Epilepsy Drugs Revenue by Countries (2013-2018)

6.2 Germany Epilepsy Drugs Revenue and Growth Rate (2013-2018)

6.3 UK Epilepsy Drugs Revenue and Growth Rate (2013-2018)

6.4 France Epilepsy Drugs Revenue and Growth Rate (2013-2018)

6.5 Russia Epilepsy Drugs Revenue and Growth Rate (2013-2018)

6.6 Italy Epilepsy Drugs Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Epilepsy Drugs Revenue by Countries

7.1 Asia-Pacific Epilepsy Drugs Revenue by Countries (2013-2018)

7.2 China Epilepsy Drugs Revenue and Growth Rate (2013-2018)

7.3 Japan Epilepsy Drugs Revenue and Growth Rate (2013-2018)

7.4 Korea Epilepsy Drugs Revenue and Growth Rate (2013-2018)

7.5 India Epilepsy Drugs Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Epilepsy Drugs Revenue and Growth Rate (2013-2018)

8 South America Epilepsy Drugs Revenue by Countries

8.1 South America Epilepsy Drugs Revenue by Countries (2013-2018)

8.2 Brazil Epilepsy Drugs Revenue and Growth Rate (2013-2018)

8.3 Argentina Epilepsy Drugs Revenue and Growth Rate (2013-2018)

8.4 Colombia Epilepsy Drugs Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Epilepsy Drugs by Countries

9.1 Middle East and Africa Epilepsy Drugs Revenue by Countries (2013-2018)

9.2 Saudi Arabia Epilepsy Drugs Revenue and Growth Rate (2013-2018)

9.3 UAE Epilepsy Drugs Revenue and Growth Rate (2013-2018)

9.4 Egypt Epilepsy Drugs Revenue and Growth Rate (2013-2018)

9.5 Nigeria Epilepsy Drugs Revenue and Growth Rate (2013-2018)

9.6 South Africa Epilepsy Drugs Revenue and Growth Rate (2013-2018)

10 Global Epilepsy Drugs Market Segment by Type

10.1 Global Epilepsy Drugs Revenue and Market Share by Type (2013-2018)

10.2 Global Epilepsy Drugs Market Forecast by Type (2018-2023)

10.3 First Generation Revenue Growth Rate (2013-2023)

10.4 Second Generation Revenue Growth Rate (2013-2023)

11 Global Epilepsy Drugs Market Segment by Application

11.1 Global Epilepsy Drugs Revenue Market Share by Application (2013-2018)

11.2 Epilepsy Drugs Market Forecast by Application (2018-2023)

11.3 Hospital Pharmacies Revenue Growth (2013-2018)

11.4 Retail Pharmacies Revenue Growth (2013-2018)

11.5 Online Pharmacies Revenue Growth (2013-2018)

12 Global Epilepsy Drugs Market Size Forecast (2018-2023)

12.1 Global Epilepsy Drugs Market Size Forecast (2018-2023)

12.2 Global Epilepsy Drugs Market Forecast by Regions (2018-2023)

12.3 North America Epilepsy Drugs Revenue Market Forecast (2018-2023)

12.4 Europe Epilepsy Drugs Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Epilepsy Drugs Revenue Market Forecast (2018-2023)

12.6 South America Epilepsy Drugs Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Epilepsy Drugs Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures



Figure Epilepsy Drugs Picture

Table Product Specifications of Epilepsy Drugs

Table Global Epilepsy Drugs and Revenue (Million USD) Market Split by Product Type

Figure Global Epilepsy Drugs Revenue Market Share by Types in 2017

Figure First Generation Picture

Figure Second Generation Picture

Table Global Epilepsy Drugs Revenue (Million USD) by Application (2013-2023)

Figure Epilepsy Drugs Revenue Market Share by Applications in 2017

Figure Hospital Pharmacies Picture

Figure Retail Pharmacies Picture

Figure Online Pharmacies Picture

Table Global Market Epilepsy Drugs Revenue (Million USD) Comparison by Regions 2013-2023

Figure North America Epilepsy Drugs Revenue (Million USD) and Growth Rate (2013-2023)

Figure Europe Epilepsy Drugs Revenue (Million USD) and Growth Rate (2013-2023)

Figure Asia-Pacific Epilepsy Drugs Revenue (Million USD) and Growth Rate (2013-2023)

Figure South America Epilepsy Drugs Revenue (Million USD) and Growth Rate (2013-2023)

Figure Middle East and Africa Epilepsy Drugs Revenue (Million USD) and Growth Rate (2013-2023)

Figure Global Epilepsy Drugs Revenue (Million USD) and Growth Rate (2013-2023)

Table Abbott Laboratories Basic Information, Manufacturing Base and Competitors

Table Abbott Laboratories Epilepsy Drugs Type and Applications

Table Abbott Laboratories Epilepsy Drugs Revenue, Gross Margin and Market Share (2016-2017)

Table GlaxoSmithKline Plc Basic Information, Manufacturing Base and Competitors

Table GlaxoSmithKline Plc Epilepsy Drugs Type and Applications

Table GlaxoSmithKline Plc Epilepsy Drugs Revenue, Gross Margin and Market Share (2016-2017)

Table UCB Basic Information, Manufacturing Base and Competitors

Table UCB Epilepsy Drugs Type and Applications

Table UCB Epilepsy Drugs Revenue, Gross Margin and Market Share (2016-2017)

Table Cephalon Basic Information, Manufacturing Base and Competitors

Table Cephalon Epilepsy Drugs Type and Applications

Table Cephalon Epilepsy Drugs Revenue, Gross Margin and Market Share (2016-2017)

Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors

Table Johnson & Johnson Epilepsy Drugs Type and Applications

Table Johnson & Johnson Epilepsy Drugs Revenue, Gross Margin and Market Share (2016-2017)

Table Pfizer Basic Information, Manufacturing Base and Competitors

Table Pfizer Epilepsy Drugs Type and Applications

Table Pfizer Epilepsy Drugs Revenue, Gross Margin and Market Share (2016-2017)

Table Novartis AG Basic Information, Manufacturing Base and Competitors

Table Novartis AG Epilepsy Drugs Type and Applications

Table Novartis AG Epilepsy Drugs Revenue, Gross Margin and Market Share (2016-2017)

Table Abbvie Basic Information, Manufacturing Base and Competitors

Table Abbvie Epilepsy Drugs Type and Applications

Table Abbvie Epilepsy Drugs Revenue, Gross Margin and Market Share (2016-2017)

Table Janssen Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Janssen Pharmaceuticals Epilepsy Drugs Type and Applications

Table Janssen Pharmaceuticals Epilepsy Drugs Revenue, Gross Margin and Market Share (2016-2017)

Table Sunovion Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Sunovion Pharmaceuticals Epilepsy Drugs Type and Applications

Table Sunovion Pharmaceuticals Epilepsy Drugs Revenue, Gross Margin and Market Share (2016-2017)

Table Valeant Pharmaceuticals International Basic Information, Manufacturing Base and Competitors

Table Valeant Pharmaceuticals International Epilepsy Drugs Type and Applications

Table Valeant Pharmaceuticals International Epilepsy Drugs Revenue, Gross Margin and Market Share (2016-2017)

Table Sanofi S.A Basic Information, Manufacturing Base and Competitors

Table Sanofi S.A Epilepsy Drugs Type and Applications

Table Sanofi S.A Epilepsy Drugs Revenue, Gross Margin and Market Share (2016-2017)

Table Shire Basic Information, Manufacturing Base and Competitors

Table Shire Epilepsy Drugs Type and Applications

Table Shire Epilepsy Drugs Revenue, Gross Margin and Market Share (2016-2017)

Table Eisai Basic Information, Manufacturing Base and Competitors

Table Eisai Epilepsy Drugs Type and Applications

Table Eisai Epilepsy Drugs Revenue, Gross Margin and Market Share (2016-2017)

Table F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors

Table F. Hoffmann-La Roche Epilepsy Drugs Type and Applications

Table F. Hoffmann-La Roche Epilepsy Drugs Revenue, Gross Margin and Market Share (2016-2017)

Table Global Epilepsy Drugs Revenue (Million USD) by Players (2013-2018)

Table Global Epilepsy Drugs Revenue Share by Players (2013-2018)

Figure Global Epilepsy Drugs Revenue Share by Players in 2016

Figure Global Epilepsy Drugs Revenue Share by Players in 2017

Figure Global Top 5 Players Epilepsy Drugs Revenue Market Share in 2017

Figure Global Top 10 Players Epilepsy Drugs Revenue Market Share in 2017

Figure Global Epilepsy Drugs Revenue (Million USD) and Growth Rate (%) (2013-2018)

Table Global Epilepsy Drugs Revenue (Million USD) by Regions (2013-2018)

Table Global Epilepsy Drugs Revenue Market Share by Regions (2013-2018)

Figure Global Epilepsy Drugs Revenue Market Share by Regions (2013-2018)

Figure Global Epilepsy Drugs Revenue Market Share by Regions in 2017

Figure North America Epilepsy Drugs Revenue and Growth Rate (2013-2018)

Figure Europe Epilepsy Drugs Revenue and Growth Rate (2013-2018)

Figure Asia-Pacific Epilepsy Drugs Revenue and Growth Rate (2013-2018)

Figure South America Epilepsy Drugs Revenue and Growth Rate (2013-2018)

Figure Middle East and Africa Epilepsy Drugs Revenue and Growth Rate (2013-2018)

Table North America Epilepsy Drugs Revenue by Countries (2013-2018)

Table North America Epilepsy Drugs Revenue Market Share by Countries (2013-2018)

Figure North America Epilepsy Drugs Revenue Market Share by Countries (2013-2018)

Figure North America Epilepsy Drugs Revenue Market Share by Countries in 2017

Figure USA Epilepsy Drugs Revenue and Growth Rate (2013-2018)

Figure Canada Epilepsy Drugs Revenue and Growth Rate (2013-2018)

Figure Mexico Epilepsy Drugs Revenue and Growth Rate (2013-2018)

Table Europe Epilepsy Drugs Revenue (Million USD) by Countries (2013-2018)

Figure Europe Epilepsy Drugs Revenue Market Share by Countries (2013-2018)

Figure Europe Epilepsy Drugs Revenue Market Share by Countries in 2017

Figure Germany Epilepsy Drugs Revenue and Growth Rate (2013-2018)

Figure UK Epilepsy Drugs Revenue and Growth Rate (2013-2018)

Figure France Epilepsy Drugs Revenue and Growth Rate (2013-2018)

Figure Russia Epilepsy Drugs Revenue and Growth Rate (2013-2018)

Figure Italy Epilepsy Drugs Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Epilepsy Drugs Revenue (Million USD) by Countries (2013-2018)

Figure Asia-Pacific Epilepsy Drugs Revenue Market Share by Countries (2013-2018)

Figure Asia-Pacific Epilepsy Drugs Revenue Market Share by Countries in 2017

Figure China Epilepsy Drugs Revenue and Growth Rate (2013-2018)

Figure Japan Epilepsy Drugs Revenue and Growth Rate (2013-2018)

Figure Korea Epilepsy Drugs Revenue and Growth Rate (2013-2018)

Figure India Epilepsy Drugs Revenue and Growth Rate (2013-2018)

Figure Southeast Asia Epilepsy Drugs Revenue and Growth Rate (2013-2018)

Table South America Epilepsy Drugs Revenue by Countries (2013-2018)

Table South America Epilepsy Drugs Revenue Market Share by Countries (2013-2018)

Figure South America Epilepsy Drugs Revenue Market Share by Countries (2013-2018)

Figure South America Epilepsy Drugs Revenue Market Share by Countries in 2017

Figure Brazil Epilepsy Drugs Revenue and Growth Rate (2013-2018)

Figure Argentina Epilepsy Drugs Revenue and Growth Rate (2013-2018)

Figure Colombia Epilepsy Drugs Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Epilepsy Drugs Revenue (Million USD) by Countries (2013-2018)

Table Middle East and Africa Epilepsy Drugs Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Epilepsy Drugs Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Epilepsy Drugs Revenue Market Share by Countries in 2017

Figure Saudi Arabia Epilepsy Drugs Revenue and Growth Rate (2013-2018)

Figure UAE Epilepsy Drugs Revenue and Growth Rate (2013-2018)

Figure Egypt Epilepsy Drugs Revenue and Growth Rate (2013-2018)

Figure Nigeria Epilepsy Drugs Revenue and Growth Rate (2013-2018)

Figure South Africa Epilepsy Drugs Revenue and Growth Rate (2013-2018)

Table Global Epilepsy Drugs Revenue (Million USD) by Type (2013-2018)

Table Global Epilepsy Drugs Revenue Share by Type (2013-2018)

Figure Global Epilepsy Drugs Revenue Share by Type (2013-2018)

Figure Global Epilepsy Drugs Revenue Share by Type in 2017

Table Global Epilepsy Drugs Revenue Forecast by Type (2018-2023)

Figure Global Epilepsy Drugs Market Share Forecast by Type (2018-2023)

Figure Global First Generation Revenue Growth Rate (2013-2018)

Figure Global Second Generation Revenue Growth Rate (2013-2018)

Table Global Epilepsy Drugs Revenue by Application (2013-2018)

Table Global Epilepsy Drugs Revenue Share by Application (2013-2018)

Figure Global Epilepsy Drugs Revenue Share by Application (2013-2018)

Figure Global Epilepsy Drugs Revenue Share by Application in 2017

Table Global Epilepsy Drugs Revenue Forecast by Application (2018-2023)

Figure Global Epilepsy Drugs Market Share Forecast by Application (2018-2023)

Figure Global Hospital Pharmacies Revenue Growth Rate (2013-2018)

Figure Global Retail Pharmacies Revenue Growth Rate (2013-2018)

Figure Global Online Pharmacies Revenue Growth Rate (2013-2018)

Figure Global Epilepsy Drugs Revenue (Million USD) and Growth Rate Forecast (2018 -2023)

Table Global Epilepsy Drugs Revenue (Million USD) Forecast by Regions (2018-2023)

Figure Global Epilepsy Drugs Revenue Market Share Forecast by Regions (2018-2023)

Figure North America Epilepsy Drugs Revenue Market Forecast (2018-2023)

Figure Europe Epilepsy Drugs Revenue Market Forecast (2018-2023)

Figure Asia-Pacific Epilepsy Drugs Revenue Market Forecast (2018-2023)

Figure South America Epilepsy Drugs Revenue Market Forecast (2018-2023)

Figure Middle East and Africa Epilepsy Drugs Revenue Market Forecast (2018-2023)



【レポートのキーワード】

てんかん薬、第一世代、第二世代、病院薬局、小売薬局、オンライン薬局

★調査レポート[てんかん薬の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)] (コード:GIR8102226)販売に関する免責事項を必ずご確認ください。
★調査レポート[てんかん薬の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆